OneMedNet Corporation offers advanced solutions for clinical imaging. Their core product, iRWD, is an artificial intelligence-driven platform that securely anonymizes, searches for, and organizes imaging data. This system is utilized by their extensive network of medical and academic research institutions, with the goa…
An institutional-grade, numbers-driven thesis on ONMD — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of July 4, 2026, TradersQuant's model rates OneMedNet Corporation (ONMD) 47/100 with a 12-month base-case forecast of $0.94 — +40.4% versus the current price of $0.67. OneMedNet Corporation trades at $0.67 in the Healthcare sector, with a market capitalisation of $36.4M. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month TradersQuant model price target for ONMD is $0.94, implying +40.4% versus the current price. The model's 12-month scenario range runs from $0.83 (bear) to $1.09 (bull), with a base case of $0.94.
On the fundamentals, OneMedNet shows a P/E of -13.8, trailing revenue of $1.4M, revenue growth of +111.4% YoY. This page also tracks ONMD's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
ONMD currently carries a TradersQuant composite score of 47/100, which we read as a cautious signal. Our 12-month price target of $0.94 implies +40.4% from $0.67. This is research, not financial advice — always combine it with your own judgement.
The TradersQuant 12-month model price target for ONMD is $0.94, about +40.4% versus the latest price of $0.67.
TradersQuant's 12-month model forecast for ONMD is a base case of $0.94, ranging from $0.83 (bear) to $1.09 (bull), an expected return of +41.1%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for ONMD over the next 12 months is $0.94 in the base case (bear $0.83, bull $1.09), versus today's price of $0.67. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for ONMD — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates ONMD's fair value at $0.83, implying +23.6% of expected upside versus the current price.
OneMedNet does not currently pay a dividend.
Data and model outputs are for research only and are not financial advice. Figures update continuously.
